SABRE THERAPEUTICS LLC has a total of 13 patent applications. Its first patent ever was published in 2014. It filed its patents most often in Australia, United States and Hong Kong. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are CHENGDU DIAO PHARMACEUTICAL GR, ALTER LAB and MITHRIDION INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | United States | 4 | |
#3 | Hong Kong | 2 | |
#4 | EAPO (Eurasian Patent Organization) | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Philippines | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Lonergan David | 13 |
#2 | Hutchinson John Howard | 12 |
#3 | Evans Jillian Frances | 5 |
#4 | Bain Gretchen | 5 |
#5 | Lai Andiliy Gokching | 1 |
#6 | Rowbottom Martin | 1 |
#7 | Hutchinson John Howard; | 1 |
Publication | Filing date | Title |
---|---|---|
US2018147185A1 | Autotaxin inhibitors and uses thereof |